URANIUM ROYALTY CORP (UROY)
CA91702V1013 - Common Stock
Taking everything into account, UROY scores 2 out of 10 in our fundamental rating. UROY was compared to 204 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of UROY is average, but there are quite some concerns on its profitability. UROY does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
UROY had positive earnings in the past year.
In the past year UROY has reported a negative cash flow from operations.
In the past 5 years UROY reported 4 times negative net income.
UROY had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 3.14%, UROY is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
UROY has a worse Return On Equity (3.17%) than 73.04% of its industry peers.
UROY has a worse Return On Invested Capital (1.59%) than 80.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.14% | ||
| ROE | 3.17% | ||
| ROIC | 1.59% |
ROA(3y)-0.67%
ROA(5y)-1.53%
ROE(3y)-0.79%
ROE(5y)-1.61%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 20.47%, UROY is in the better half of the industry, outperforming 65.20% of the companies in the same industry.
UROY has a worse Operating Margin (13.04%) than 62.25% of its industry peers.
UROY has a Gross Margin of 34.55%. This is comparable to the rest of the industry: UROY outperforms 42.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.04% | ||
| PM (TTM) | 20.47% | ||
| GM | 34.55% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), UROY is destroying value.
UROY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for UROY has been increased compared to 5 years ago.
UROY has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 107.84 indicates that UROY is not in any danger for bankruptcy at the moment.
UROY's Altman-Z score of 107.84 is amongst the best of the industry. UROY outperforms 99.51% of its industry peers.
UROY has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, UROY belongs to the best of the industry, outperforming 80.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 107.84 |
ROIC/WACC0.21
WACC7.53%
2.3 Liquidity
A Current Ratio of 84.03 indicates that UROY has no problem at all paying its short term obligations.
The Current ratio of UROY (84.03) is better than 99.51% of its industry peers.
A Quick Ratio of 16.19 indicates that UROY has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 16.19, UROY belongs to the best of the industry, outperforming 98.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 84.03 | ||
| Quick Ratio | 16.19 |
3. Growth
3.1 Past
UROY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 215.68%, which is quite impressive.
The Revenue has grown by 208.35% in the past year. This is a very strong growth!
EPS 1Y (TTM)215.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%343%
Revenue 1Y (TTM)208.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.83%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 60.10, UROY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of UROY indicates a slightly more expensive valuation: UROY is more expensive than 76.47% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 31.46, UROY is valued quite expensively.
Based on the Price/Forward Earnings ratio of 58.74, the valuation of UROY can be described as expensive.
Based on the Price/Forward Earnings ratio, UROY is valued a bit more expensive than 74.02% of the companies in the same industry.
UROY's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.63.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.1 | ||
| Fwd PE | 58.74 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UROY is valued a bit more expensive than the industry average as 79.90% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 85.5 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for UROY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
URANIUM ROYALTY CORP
NASDAQ:UROY (10/22/2024, 3:08:06 PM)
3.005
-0.08 (-2.44%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap365.12M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.1 | ||
| Fwd PE | 58.74 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.14% | ||
| ROE | 3.17% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 13.04% | ||
| PM (TTM) | 20.47% | ||
| GM | 34.55% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 84.03 | ||
| Quick Ratio | 16.19 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)215.68%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y0%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)208.35%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y